| Literature DB >> 12873514 |
Philippe G Nantermet1, James C Barrow, Christina L Newton, Janetta M Pellicore, MaryBeth Young, S Dale Lewis, Bobby J Lucas, Julie A Krueger, Daniel R McMasters, Youwei Yan, Lawrence C Kuo, Joseph P Vacca, Harold G Selnick.
Abstract
A series of potent and selective proline- and pyrazinone-based macrocyclic thrombin inhibitors is described. Detailed SAR studies led to the incorporation of specific functional groups in the tether that enhanced functional activity against thrombin and provided exquisite selectivity against trypsin and tPA. X-ray crystallography and molecular modeling studies revealed the inhibitor-enzyme interactions responsible for this selectivity.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12873514 DOI: 10.1016/s0960-894x(03)00506-7
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823